Critical Evaluation of Current Treatments in Metastatic Colorectal Cancer

Critical Evaluation of Current Treatments in Metastatic Colorectal Cancer Alan Venook Oncologist 2005; 10: 250-261 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the evolution of cancer chemotherapy for patients with colorectal cancer. Discuss the current relevance of VEGF as a therapeutic target in colorectal cancer. Discuss the current relevance of EGFR as a therapeutic target in colorectal cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Apr. 8, 2005 Most Recent Review: Apr. 8, 2005* Most Recent Update: Apr. 8, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.